Detalhe da pesquisa
1.
Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study.
Lancet Oncol
; 25(2): 255-264, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38142702
2.
PEC-PRO: A new prognostic score from a series of 87 patients with localized perivascular epithelioid cell neoplasms (PEComas) treated with curative intent.
Cancer
; 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38470379
3.
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.
N Engl J Med
; 385(8): 683-694, 2021 08 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34407342
4.
Late toxicity comparison of alkylating-based maintenance regimen with cyclophosphamide (VAC) vs ifosfamide (VAI) in Ewing sarcoma survivors treated in the randomized clinical trial Euro-EWING99-R1 in France.
Int J Cancer
; 152(8): 1659-1667, 2023 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36250317
5.
Regorafenib in patients with advanced Ewing sarcoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre Phase II study.
Br J Cancer
; 129(12): 1940-1948, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37914801
6.
Initial Active Surveillance Strategy for Patients with Peripheral Sporadic Primary Desmoid-Type Fibromatosis: A Multicentric Phase II Observational Trial.
Ann Surg Oncol
; 30(13): 8653-8659, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37777684
7.
Management and outcomes of adolescent and young adult sarcoma patients: results from the French nationwide database NETSARC.
BMC Cancer
; 23(1): 69, 2023 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36670431
8.
Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy for metastatic or unresectable leiomyosarcoma (LMS-04): a randomised, multicentre, open-label phase 3 trial.
Lancet Oncol
; 23(8): 1044-1054, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35835135
9.
Nivolumab, nivolumab-ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial.
Lancet Oncol
; 23(5): 612-624, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35390339
10.
Treatment of 120 adult osteosarcoma patients with metachronous and synchronous metastases: A retrospective series of the French Sarcoma Group.
Int J Cancer
; 150(4): 645-653, 2022 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34562271
11.
Rare bone sarcomas: A retrospective analysis of 145 adult patients from the French Sarcoma Group.
Int J Cancer
; 150(5): 825-836, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34611903
12.
Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma.
N Engl J Med
; 379(5): 417-427, 2018 Aug 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29860937
13.
Determinants of the access to remote specialised services provided by national sarcoma reference centres.
BMC Cancer
; 21(1): 631, 2021 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34049529
14.
Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trial.
Lancet Oncol
; 21(3): 446-455, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32078813
15.
Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
Cancer
; 126(11): 2637-2647, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32129883
16.
Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long-term follow-up of the randomized, open-label, phase 3 CheckMate 025 trial.
Cancer
; 126(18): 4156-4167, 2020 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32673417
17.
Value of peri-operative chemotherapy in patients with CINSARC high-risk localized grade 1 or 2 soft tissue sarcoma: study protocol of the target selection phase III CHIC-STS trial.
BMC Cancer
; 20(1): 716, 2020 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-32736540
18.
Pharmacokinetic and Pharmacogenetic Study of Etoposide in High-Dose Protocol (TI-CE) for Advanced Germ Cell Tumors.
Pharm Res
; 37(7): 147, 2020 Jul 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32676789
19.
Rhabdomyosarcoma associated with germline TP53 alteration in children and adolescents: The French experience.
Pediatr Blood Cancer
; 67(9): e28486, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32658383
20.
Progressive Desmoid Tumor: Radiomics Compared With Conventional Response Criteria for Predicting Progression During Systemic Therapy-A Multicenter Study by the French Sarcoma Group.
AJR Am J Roentgenol
; 215(6): 1539-1548, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32991215